Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
26/06/2023 | 12:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:YCBD | cbdMD Inc |
05/05/2023 | 21:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:YCBD | cbdMD Inc |
03/05/2023 | 12:02 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:YCBD | cbdMD Inc |
30/03/2023 | 22:06 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | AMEX:YCBD | cbdMD Inc |
07/03/2023 | 18:33 | Business Wire | cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF’s Certified for Sport® Certifications | AMEX:YCBD | cbdMD Inc |
03/03/2023 | 22:02 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:YCBD | cbdMD Inc |
13/02/2023 | 22:08 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:YCBD | cbdMD Inc |
13/01/2023 | 22:16 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:YCBD | cbdMD Inc |
04/01/2023 | 15:07 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:YCBD | cbdMD Inc |
23/12/2022 | 22:07 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | AMEX:YCBD | cbdMD Inc |
20/12/2022 | 22:03 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | AMEX:YCBD | cbdMD Inc |
15/12/2022 | 22:07 | Edgar (US Regulatory) | Annual Report (10-k) | AMEX:YCBD | cbdMD Inc |
12/08/2022 | 22:04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | AMEX:YCBD | cbdMD Inc |
12/08/2022 | 00:33 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:YCBD | cbdMD Inc |
14/06/2022 | 13:18 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | AMEX:YCBD | cbdMD Inc |
22/04/2022 | 12:10 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | AMEX:YCBD | cbdMD Inc |
05/04/2022 | 22:37 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | AMEX:YCBD | cbdMD Inc |
03/03/2022 | 15:30 | Business Wire | cbdMD Expands Product Offering and Nationwide Footprint with Major Retail Partner GNC | AMEX:YCBD | cbdMD Inc |
22/02/2022 | 16:45 | Business Wire | cbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD’s Extensive Safety Submission | AMEX:YCBD | cbdMD Inc |
17/02/2022 | 14:30 | Business Wire | cbdMD Becomes First American CBD Brand to Receive Validation by the United Kingdom Food Standards Agency | AMEX:YCBD | cbdMD Inc |
10/02/2022 | 22:10 | Business Wire | cbdMD Completes Third Full Year Results; Total Brands Sales of $118.7 Million Exceeds Initial Earn Out Target | AMEX:YCBD | cbdMD Inc |
07/02/2022 | 14:00 | Business Wire | cbdMD Becomes the First CBD Company to Earn Prestigious NSF International’s Certified for Sport® Certification | AMEX:YCBD | cbdMD Inc |
24/01/2022 | 22:15 | Business Wire | cbdMD, Inc. To Host Conference Call To Discuss December 31, 2021, First Quarter Results | AMEX:YCBD | cbdMD Inc |
17/12/2021 | 22:10 | Business Wire | cbdMD Reports Fiscal Year Net Sales Increased 6.2% To Record $44.5 Million | AMEX:YCBD | cbdMD Inc |
16/12/2021 | 22:21 | Business Wire | Due To Technical Difficulties, cbdMD, Inc. Moves Conference Call To Discuss September 30, 2021, Fourth Quarter and Fiscal Year Results To December 17, 2021 at 4:15 pm EST | AMEX:YCBD | cbdMD Inc |
03/12/2021 | 15:30 | Business Wire | cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina | AMEX:YCBD | cbdMD Inc |
02/12/2021 | 22:30 | Business Wire | cbdMD, Inc. To Host Conference Call To Discuss September 30, 2021 Fourth Quarter and Fiscal Year Results | AMEX:YCBD | cbdMD Inc |
01/12/2021 | 14:30 | Business Wire | cbdMD Announces Hiring of Consumer Goods Veteran Dave Johnson To Drive FDM Distribution Channel & Business Development | AMEX:YCBD | cbdMD Inc |
29/11/2021 | 14:30 | Business Wire | cbdMD Announces Exclusive Multi-Year Partnership With Amazon Platform Partner Amify | AMEX:YCBD | cbdMD Inc |
18/11/2021 | 14:00 | Business Wire | cbdMD Extends Partnership with Spotify and Joe Rogan as Exclusive CBD Advertiser | AMEX:YCBD | cbdMD Inc |